Corbacioglu, S. (2012) Early Phase Clinical Trials in Pediatric Hematology and Oncology. KLINISCHE PADIATRIE, 224 (3). pp. 197-200. ISSN 0300-8630, 1439-3824
Full text not available from this repository. (Request a copy)Abstract
Pediatric oncology is an unrivaled success story in the recent history of medicine. This success is mostly based on a persistent refinement of evidence based therapeutic concepts. With that regard physicians and their staff are highly experience in the conduct of prospective evidence based trials and are therefore competent partners for the pharmaceutical industry. In times of personalized medicine the individual target population is diminishing and the borders of indications are not more disease based. A situation that requires new concepts from the industry. Therefore children with cancer could benefit early from the current developments as well as the pharmaceutical industry could benefit from the legislative incentives through highly recruiting and well conducted prospective trials. Pivotal is a functional platform of communication in order to maintain a close dialogue between academia and pharmaceutical companies.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | LABEL DRUG-USE; CHILDHOOD-CANCER; ADULT SURVIVORS; CHILDREN; IMPACT; CARE; LEUKEMIA; AGENTS; WARDS; pediatric oncoclogy; children; phase 1 clinical trials; phase 2 clinical trials |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 14 May 2020 06:02 |
| Last Modified: | 14 May 2020 06:02 |
| URI: | https://pred.uni-regensburg.de/id/eprint/18768 |
Actions (login required)
 |
View Item |
